Accès gratuit
Numéro
Med Sci (Paris)
Volume 31, Numéro 2, Février 2015
Page(s) 151 - 158
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153102011
Publié en ligne 4 mars 2015
  1. Global initiative for asthma (GINA). Burden Report 2004. Available at: www.ginasthma.org.
  2. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World health organization, GA(2)LEN and AllerGen). Allergy 2008 ; 63 : (suppl 86) 8–160. [CrossRef] [PubMed]
  3. Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev 2011 ; 242 : 31–50. [CrossRef] [PubMed]
  4. Soroosh P, Doherty TA. Th9 and allergic disease. Immunology 2009 ; 127 : 450–458. [CrossRef] [PubMed]
  5. Cosmi L, Liotta F, Maggi E, et al. Th17 cells: new players in asthma pathogenesis. Allergy 2011 ; 66 : 989–998. [CrossRef] [PubMed]
  6. Lambrecht BN, Hammad H. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 2010 ; 376 : 835–843. [CrossRef] [PubMed]
  7. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973 ; 137 : 1142–1162. [CrossRef] [PubMed]
  8. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996 ; 93 : 2588–2592. [CrossRef]
  9. Reizis B, Bunin A, Ghosh HS, et al. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 2011 ; 29 : 163–183. [CrossRef] [PubMed]
  10. Segura E, Amigorena S. Inflammatory dendritic cells in mice and humans. Trends Immunol 2013 ; 34 : 440–445. [CrossRef]
  11. Plantinga M, Guilliams M, Vanheerswynghels M, et al. Conventional and monocyte-derived CD11b+ dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013 ; 38 : 322–335. [CrossRef] [PubMed]
  12. Demedts IK, Brusselle GG, Vermaelen KY, Pauwels RA. Identification and characterization of human pulmonary dendritic cells. Am J Respir Cell Mol Biol 2005 ; 32 : 177–184. [CrossRef] [PubMed]
  13. Haniffa M, Shin A, Bigley V, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 2012 ; 37 : 60–73. [CrossRef] [PubMed]
  14. Segura E, Touzot M, Bohineust A, et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013 ; 38 : 336–348. [CrossRef] [PubMed]
  15. Andersson LI, Cirkic E, Hellman P, Eriksson H. Myeloid blood dendritic cells and monocyte-derived dendritic cells differ in their endocytosing capability. Hum Immunol 2012 ; 73 : 1073–1081. [CrossRef] [PubMed]
  16. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998 ; 160 : 4090–4097. [PubMed]
  17. De Heer HJ, Hammad H, Soullie T, et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004 ; 200 : 89–98. [CrossRef] [PubMed]
  18. Nakano H, Free ME, Whitehead GS, et al. Pulmonary CD103+ dendritic cells prime Th2 responses to inhaled allergens. Mucosal Immunol 2012 ; 5 : 53–65. [CrossRef] [PubMed]
  19. Hammad H. Th2 polarization by Der p 1-pulsed monocyte-derived dendritic cells is due to the allergic status of the donors. Blood 2001 ; 98 : 1135–1141. [CrossRef] [PubMed]
  20. Charbonnier AS. Der p 1-pulsed myeloid and plasmacytoid dendritic cells from house dust mite-sensitized allergic patients dysregulate the T cell response. J Leukoc Biol 2003 ; 73 : 91–99. [CrossRef] [PubMed]
  21. Farrell E, O’Connor TM, Duong M, et al. Circulating myeloid and plasmacytoid dendritic cells after allergen inhalation in asthmatic subjects. Allergy 2007 ; 62 : 1139–1145. [CrossRef] [PubMed]
  22. Dua B, Watson RM, Gauvreau GM, O’Byrne PM. Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J Allergy Clin Immunol 2010 ; 126 : 133–139. [CrossRef] [PubMed]
  23. Upham JW, Denburg JA, O’Byrne PM. Rapid response of circulating myeloid dendritic cells to inhaled allergen in asthmatic subjects. Clin Exp Allergy 2002 ; 32 : 818–823. [CrossRef] [PubMed]
  24. Dua B, Smith S, Kinoshita T, et al. Myeloid dendritic cells type 2 in allergic asthma. Allergy 2013 ; 68 : 1322–1326. [CrossRef] [PubMed]
  25. Dua B, Tang W, Watson R, et al. Myeloid dendritic cells type 2 after allergen inhalation in asthmatic subjects. Clin Exp Allergy 2014 ; 44 : 921–929. [CrossRef] [PubMed]
  26. Foster B, Metcalfe DD, Prussin C. Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma. J Allergy Clin Immunol 2003 ; 112 : 1132–1138. [CrossRef] [PubMed]
  27. Maurer D, Fiebiger S, Ebner C, et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996 ; 157 : 607–616. [PubMed]
  28. Greer AM, Wu N, Putnam AL, et al. Serum IgE clearance is facilitated by human FcepsilonRI internalization. J Clin Invest 2014 ; 124 : 1187–1198. [CrossRef] [PubMed]
  29. Shen C, Hupin C, Froidure A, et al. Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma. Clin Exp Allergy 2014 ; 44 : 831–841. [CrossRef] [PubMed]
  30. Pilette C, Jacobson MR, Ratajczak C, et al. Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis. Allergy 2013 ; 68 : 312–321. [CrossRef] [PubMed]
  31. Platts-Mills TA, Woodfolk JA. Allergens and their role in the allergic immune response. Immunol Rev 2011 ; 242 : 51–68. [CrossRef] [PubMed]
  32. Hammad H, Chieppa M, Perros F, et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009 ; 15 : 410–416. [CrossRef] [PubMed]
  33. Ito T, Wang YH, Duramad O, et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005 ; 202 : 1213–1223. [CrossRef] [PubMed]
  34. Shikotra A, Choy DF, Ohri CM, et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J Allergy Clin Immunol 2012 ; 129 : 104–11 e1–e9. [CrossRef]
  35. Jiang H, Hener P, Li J, Li M. Skin thymic stromal lymphopoietin promotes airway sensitization to inhalant house dust mites leading to allergic asthma in mice. Allergy 2012 ; 67 : 1078–1082. [CrossRef] [PubMed]
  36. Xu G, Zhang L, Wang DY, et al. Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells. Allergy 2010 ; 65 : 581–589. [CrossRef] [PubMed]
  37. Zhu Z, Oh MH, Yu J, et al. The role of TSLP in IL-13-induced atopic march. Sci Rep 2011 ; 1 : 23. [PubMed]
  38. Froidure A, Shen C, Gras D, et al. Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy 2014 ; 69 : 1068–1076. [CrossRef] [PubMed]
  39. Lambrecht BN, Hammad H. Asthma: the importance of dysregulated barrier immunity. Eur J Immunol 2013 ; 43 : 3125–3137. [CrossRef] [PubMed]
  40. Chu DK, Llop-Guevara A, Walker TD, et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol 2013 ; 131 : 187–200 e1–e8.
  41. Willart MA, Deswarte K, Pouliot P, et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 2012 ; 209 : 1505–1517. [CrossRef] [PubMed]
  42. Barnes PJ. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 1998 ; 102 : 531–538. [CrossRef] [PubMed]
  43. Moller GM, Overbeek SE, Van Helden-Meeuwsen CG, et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996 ; 26 : 517–524. [CrossRef] [PubMed]
  44. Krzysiek R. Role of glucocorticoid-induced leucine zipper (GILZ) expression by dendritic cells in tolerance induction. Transplant Proc 2010 ; 42 : 3331–3332. [CrossRef] [PubMed]
  45. Humbert M, Beasley R, Ayres J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005 ; 60 : 309–316. [CrossRef] [PubMed]
  46. Chanez P, Contin-Bordes C, Garcia G, et al. Omalizumab-induced decrease of FcxiRI expression in patients with severe allergic asthma. Respir Med 2010 ; 104 : 1608–1617. [CrossRef] [PubMed]
  47. Schroeder JT, Bieneman AP, Chichester KL, et al. Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization. J Allergy Clin Immunol 2010 ; 125 : 896–901. [CrossRef] [PubMed]
  48. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 2014 ; 133 : 621–631. [CrossRef] [PubMed]
  49. Chen ZG, Zhang TT, Li HT, et al. Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PLoS One 2013 ; 8 : e51268. [CrossRef] [PubMed]
  50. Cheng DT, Ma C, Niewoehner J, et al. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. J Allergy Clin Immunol 2013 ; 132 : 455–462. [CrossRef] [PubMed]
  51. Lee HY, Rhee CK, Kang JY, et al. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res 2014 ; 40 : 66–76. [CrossRef] [PubMed]
  52. Gauvreau GM, O’Byrne PM, Boulet LP, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 2014 ; 370 : 2102–2110. [CrossRef] [PubMed]
  53. Zitvogel L, Amigorena S, Teillaud JL. À propos de Ralph M. Steinman et des cellules dendritiques. Prix Nobel de Médecine 2011. Med Sci (Paris) 2011 ; 27 : 1028–1034. [CrossRef] [EDP Sciences] [PubMed]
  54. Crozat K, Dalod M. Les cellules dendritiques humaines exprimant BDCA3. Med Sci (Paris) 2011 ; 27 : 25–28. [CrossRef] [EDP Sciences] [PubMed]
  55. Henri S, Poulin L, Malissen B. Le derme de la peau s’enrichit d’une nouvelle population de cellules dendritiques. Med Sci (Paris) 2008 ; 24 : 346–347. [CrossRef] [EDP Sciences] [PubMed]
  56. Segura E, Amigorena S. Les cellules dendritiques inflammatoires. Med Sci (Paris) 2014 ; 30 : 64–68. [CrossRef] [EDP Sciences]
  57. Pépin A, Biola-Vidamment A, Latré de Laté P, et al. Les protéines de la famille TSC-22D : de nouveaux régulateurs de l’homéostasie cellulaire ? Med Sci (Paris) 2015 ; 31 : 75–83. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.